Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/52682
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMorrow A.-
dc.contributor.authorSpeechly C.-
dc.contributor.authorYoung A.L.-
dc.contributor.authorTucker K.-
dc.contributor.authorHarris R.-
dc.contributor.authorPoplawski N.-
dc.contributor.authorAndrews L.-
dc.contributor.authorNguyen Dumont T.-
dc.contributor.authorKirk J.-
dc.contributor.authorSouthey M.C.-
dc.contributor.authorWillis A.-
dc.date.accessioned2024-11-22T03:37:16Z-
dc.date.available2024-11-22T03:37:16Z-
dc.date.copyright2024-
dc.date.issued2024-10-16en
dc.identifier.citationJournal of Genetic Counseling. 33(5) (pp 973-984), 2024. Date of Publication: 01 Oct 2024.-
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/52682-
dc.description.abstractIn the genomic era, the availability of gene panel and whole genome/exome sequencing is rapidly increasing. Opportunities for providing former patients with new genetic information are also increasing over time and recontacting former patients with new information is likely to become more common. Breast cancer Refined Analysis of Sequence Tests-Risk And Penetrance (BRA-STRAP) is an Australian study of individuals who had previously undertaken BRCA1 and BRCA2 genetic testing, with no pathogenic variants detected. Using a waiver of consent, stored DNA samples were retested using a breast/ovarian cancer gene panel and clinically significant results returned to the patient (or next of kin, if deceased). This qualitative study aimed to explore patient experiences, opinions, and expectations of recontacting in the Australian hereditary cancer setting. Participants were familial cancer clinic patients (or next of kin) who were notified of a new pathogenic variant identified via BRA-STRAP. In-depth, semi-structured interviews were conducted approximately 6weeks post-result. Interviews were transcribed verbatim and analyzed using an inductive thematic approach. Thirty participants (all female; average age=57; range 36-84) were interviewed. Twenty-five were probands, and five were next of kin. Most women reported initial shock upon being recontacted with unexpected news, after having obtained a sense of closure related to their initial genetic testing experiences and cancer diagnosis. For most, this initial distress was short-lived, followed by a process of readjustment, meaning-making and adaptation that was facilitated by perceived clinical and personal utility of the information. Women were overall satisfied with the waiver of consent approach and recontacting process. Results are in line with previous studies suggesting that patients have positive attitudes about recontacting. Women in this study valued new genetic information gained from retesting and were satisfied with the BRA-STRAP recontact model. Practice implications to facilitate readjustment and promote psychosocial adaptation were identified.Copyright © 2023 The Authors. Journal of Genetic Counseling published by Wiley Periodicals LLC on behalf of National Society of Genetic Counselors.-
dc.relation.ispartofJournal of Genetic Counseling-
dc.subject.meshbreast tumor-
dc.subject.meshgenetics-
dc.subject.meshpsychology-
dc.title"Out of the blue": a qualitative study exploring the experiences of women and next of kin receiving unexpected results from bra-strap research gene panel testing.-
dc.typeArticle-
dc.identifier.affiliationMonash University - School of Clinical Sciences at Monash Health-
dc.type.studyortrialQualitative study-
dc.identifier.doihttps://dx.doi.org/10.1002/jgc4.1803-
dc.publisher.placeUnited States-
dc.identifier.pubmedid37864663 [https://www.ncbi.nlm.nih.gov/pubmed/?term=37864663]-
dc.identifier.institution(Morrow) School of Population Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia-
dc.identifier.institution(Morrow, Speechly, Tucker, Andrews) Hereditary Cancer Centre, Prince of Wales Hospital, Randwick, NSW, Australia-
dc.identifier.institution(Young, Andrews) School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia-
dc.identifier.institution(Tucker) UNSW Prince of Wales Clinical School, Randwick, NSW, Australia-
dc.identifier.institution(Harris, Kirk) Westmead Hospital Familial Cancer Service, Crown Princess Mary Cancer Centre, Westmead, NSW, Australia-
dc.identifier.institution(Poplawski) Adult Genetics Unit, Royal Adelaide Hospital, Adelaide, SA, Australia-
dc.identifier.institution(Poplawski) Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia-
dc.identifier.institution(Nguyen Dumont, Southey) Department of Clinical Pathology, Melbourne Medical School, University of Melbourne, Parkville, VIC, Australia-
dc.identifier.institution(Nguyen Dumont, Southey) Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia-
dc.identifier.institution(Southey) Cancer Council Victoria, Melbourne, VIC, Australia-
dc.identifier.institution(Willis) Clinical Translation and Engagement Platform, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia-
dc.identifier.institution(Willis) School of Clinical Medicine, UNSW Medicine & Health, Faculty of Medicine and Health, University of New South Wales, St Vincent's Healthcare Clinical Campus, Sydney, NSW, Australia-
dc.identifier.affiliationmh(Nguyen Dumont, Southey) Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia-
item.openairetypeArticle-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:Articles
Show simple item record

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.